Stay updated on IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial
Sign up to get notified when there's something new on the IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial page.

Latest updates to the IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe footer revision number changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedA new revision entry, v3.7.0, was added to the study record history. The previous revision, v3.6.6, was removed.SummaryDifference0.1%

- Check48 days agoChange DetectedThe history now shows a new Revision: v3.6.6 entry, replacing the previous Revision: v3.6.5. This marks an update to the study record's version in the history.SummaryDifference0.1%

- Check69 days agoChange DetectedThe history list now shows a new revision tag v3.6.5, while the previous v3.6.4 tag is removed, indicating an updated documentation version of the record.SummaryDifference0.1%

- Check83 days agoChange DetectedThe record history now lists a new Revision: v3.6.4 as the latest entry, replacing the previous v3.6.3, indicating a small update to the page's versioning.SummaryDifference0.1%

- Check112 days agoChange DetectedA new revision entry 'Revision: v3.6.3' appears in the study history, indicating an internal page update. The visible study information and layout appear unchanged.SummaryDifference0.1%

Stay in the know with updates to IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial page.